By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 105
NEW YORK (Reuters Health) – Results of the Infant Cooling Evaluation (ICE) trial confirm that moderate therapeutic hypothermia reduces death and disability in term and near-term infants who…
NEW YORK (Reuters Health) – Fifteen years after postoperative pelvic radiotherapy for endometrial carcinoma, many women still suffer from urinary and bowel symptoms and have reduced physical functioning,…
NEW YORK (Reuters Health) – A pH-balanced vaginal gel can alleviate vulvovaginal symptoms after treatment for breast cancer, according to results of randomized controlled study published in the…
NEW YORK (Reuters Health) – A study from Japan finds that sodium bicarbonate plus sodium chloride is more effective than sodium chloride alone for the prevention of contrast-induced…
NEW YORK (Reuters Health) – When the infusion time of high-dose methotrexate (HDMTX) is shortened from 24 hours to 4 hours in cases of childhood acute lymphoblastic leukemia…
NEW YORK (Reuters Health) – Urologists outline the best evidence-based management of postprostatectomy incontinence in a new review published in European Urology. Despite improved surgical techniques, the prevalence…
NEW YORK (Reuters Health) – With guidance and training, certain patients on long-term anticoagulant therapy can safely monitor their own INR levels and make dose adjustments as needed,…
NEW YORK (Reuters Health) – After percutaneous coronary intervention via the femoral artery, use of arterial closure devices rather than manual compression reduces the rate of major bleeding…
NEW YORK (Reuters Health) – A low-dose oral contraceptive is effective in relieving primary dysmenorrhea, according to the results of a randomized controlled trial conducted in Japan and…
NEW YORK (Reuters Health) – Patients with advanced cervical carcinoma have better progression-free survival when gemcitabine is added to concurrent cisplatin chemoradiotherapy and included in adjuvant therapy, an…
